Your Daily Horoscope Today highlights deep analytical focus, lucrative corporate partnerships, and sharp daily problem-solving skills. Alig...

Your Daily Horoscope Today highlights creative leadership, workplace foundation building, and active short-term communication gains. Aligni...

Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as...

Aditya Agarwal, managing partner at SPC, and Prateek Mehta, general partner-India, told ET in an exclusive interaction that the firm is see...

The Silicon Valley-headquartered VC firm is betting on India’s IPO-led liquidity opportunity. Accel aims to invest early and help companies...

Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...

APMI appointed Vikas Khemani as Chairman and Sandeep Jethwani as Vice-Chairman following its August 10 board meeting. The new leadership wi...

Planning an international trip? A 'zero forex markup' credit card promises savings, but hidden charges and fluctuating exchange rates can s...

Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...

Europe's stock market is experiencing a robust rally, attracting significant investor interest. Strong earnings growth and improving econom...

Legendary investor Peter Lynch’s investing philosophy emphasises understanding what you own, conducting thorough research and focusing on a...

Happy Friday! Nazara Technologies will raise funds via a preferential issue. This and more in today’s ETtech Morning Dispatch.

The fundraise comes just after a leadership change with founder Nitish Mittersain stepping down as chief executive from September 1 while c...

Baroda BNP Paribas Mutual Fund raised over Rs 1,200 crore through its ESG Best-in-Class Strategy Fund and Services Fund launches in 2026. T...

Asia’s major multi-strategy funds suffered sharp July losses as an AI-linked stock selloff across Japan, South Korea and China erased much ...

Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue...

Macquarie Asset Management has invested over four billion dollars in India during its two decades. The firm is now actively evaluating digi...